CorEvitas, LLC

CorEvitas, LLC, established in 2000 and headquartered in the United States, has positioned itself as a leader in providing science-led, regulatory grade real-world evidence and clinical insights for post-approval safety and effectiveness of novel therapies. The company's offerings include syndicated registry data, analytics, patient experience and insights, precision medicine solutions, and specialty EMR and claims data. Its slogan, "Regulatory grade real-world evidence and clinical insights on post approval safety and effectiveness for novel therapies," encapsulates its focus. CorEvitas, LLC's significant investment milestone was marked by a Private Equity Round investment on 19 December 2019, with the backing of investors including Audax Private Equity and Ardan Equity. The firm's impact within the life sciences industry is underscored by its contribution to hundreds of peer-reviewed manuscripts and abstracts, underscoring its pivotal role in supporting regulatory commitments for new drug approvals through active safety surveillance and formal post-authorization safety studies. As the company continues to bolster its presence in the Analytics, Biopharma, Biotechnology, and Health Care sectors, CorEvitas, LLC sets itself apart with its provision of objective clinical insights, shaping the landscape for evidence-based decision-making in the healthcare and life sciences domains.